Agilent Technologies Inc. (A)
Summary
Agilent Strengthens Biopharma Growth Prospects With AI Expansion
A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.
Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock?
Canadian Apartment REIT: A 4.5% Dividend Yield With Ample Coverage
Canadian Apartment Properties REIT trades at 15x AFFO and nearly 40% below NAV, offering compelling value. Q1 AFFO per share declined just 1.5% to C$0.513, with a strong 70% payout ratio and robust distribution coverage. Active buybacks and retained AFFO (~C$100 million/year) support growth initiatives and the development pipeline.
Agilent Technologies Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 6,213 | $847,563.11 | $843,694.33 | -$3,868.78 | -0.46% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 3,507 | $559,593.86 | $476,233.06 | -$83,360.8 | -14.9% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 2,687 | $262,508.84 | $364,881.16 | $102,372.32 | 39% |
| CE Curtis Ellergodt Rothschild Investment LLC | 1,144 | $149,775.33 | $155,349.48 | $5,574.15 | 3.72% |
| PER Paul E. Rasmussen SIT INVESTMENT ASSOCIATES Inc. | 65,552 | $7.69M | $8.9M | $1.21M | 15.72% |
Agilent Technologies Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Brandon Couillard Wells Fargo | 203.3 | $27,529.97 | $26,987.49 | -$542.48 | -1.97% |
Agilent Technologies Inc. (A) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Agilent Technologies Inc. ever had a stock split?
Agilent Technologies Inc. Profile
| Professional Services Industry | Industrials Sector | Padraig McDonnell CEO | NYSE Exchange | 00846U101 CUSIP |
| US Country | 17,900 Employees | 30 Jun 2026 Last Dividend | 3 Nov 2014 Last Split | - IPO Date |
Overview
Agilent Technologies, Inc. stands as a global provider offering application-focused solutions primarily to the life sciences, diagnostics, and applied chemical sectors. The company propagates its mission across three distinct segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab, ensuring a broad spectrum of scientific research, diagnostic, and analytical needs are met worldwide. Since its establishment in 1999, Agilent has cemented its headquarters in Santa Clara, California, from where it orchestrates its global operations, offering an expansive portfolio through direct sales, distributors, resellers, and electronic commerce frameworks.
Products and Services
- Life Sciences and Applied Markets: This segment includes a vast array of technologies such as liquid and gas chromatography systems and components, mass spectrometry systems, spectroscopy instruments, and various laboratory software solutions. It extends to capturing cell analysis with plate-based assays, flow cytometers, real-time cell analyzers, and cell imaging systems, supported by laboratory automation and robotic systems. The emphasis on quality is further underscored by their vacuum pumps and measurement technologies, ensuring precision and efficiency in research and diagnostic activities.
- Diagnostics and Genomics: Emphasizing the critical nature of genomics and nucleic acid research, this segment covers the bases from contract manufacturing to pathology and companion diagnostics. It spans a spectrum that includes reagent partnerships and biomolecular analysis, facilitating advanced diagnostics and extensive research capabilities in the genomic space. This commitment is aimed at pushing the boundaries of molecular diagnostics, providing comprehensive solutions for research and clinical applications.
- Agilent CrossLab: A testament to Agilent’s overarching commitment to support and service, the CrossLab segment provides an exhaustive list of laboratory instrument supplies, including GC and LC columns, sample preparation products, and custom chemistries. Beyond products, CrossLab’s service portfolio is robust, offering everything from repairs, parts, and maintenance to installations, training, and compliance support. With software as a service, asset management, and consulting services, this segment is designed to optimize laboratory operations and enhance the productivity and longevity of research investments.
